Stock Updates

Today’s Top Gainers in the Market IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Healthcare

Today’s top gainers include the company IDEXX Laboratories, Inc. (NASDAQ:IDXX) which is in the industry Diagnostic Substances, gaining 1.17% today. In the last week its performance is -0.24%, and 18.18% for the past quarter. Currently, IDEXX Laboratories, Inc., IDXX has a target price of 116.8, so today’s gain of 1.17% is a significant step towards its target price. The GAP today is therefore 1.20%.

IDEXX Laboratories, Inc. (NASDAQ:IDXX), has a market cap of 10045.75, and is based in USA. Insider ownership is at 1.30%, and institutional ownership is 94.80%.

At the current price of 112.57, it has a dividend yield of *TBA, and its target price is 116.8. This is with a profit margin of 11.90%, and total debt/equity of *TBA. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has a P/E of 50.96, as well as a forward P/E of 41.79.

With a current EPS of 2.21, and a forecasted EPS growth for next year at 14.10%,IDEXX Laboratories, Inc. (NASDAQ:IDXX) has had a EPS growth for the past five years at 11.60%. For the next five years EPS growth is projected to be 14.35%.

Performance for the year is 51.67%. Since its IPO date on 6/24/1991, the total performance to date is 54.37%.

Volume today for IDEXX Laboratories, Inc. (NASDAQ:IDXX), is 344100, while its average volume is 493.33. Whilst the total gain today was 1.17%, it did have a day high of -4.47%.

Volatility for this week has been at 1.27%, and 1.61% for the month. The 52-week low for IDEXX Laboratories, Inc., IDXX has been 77.33%, while the 52-week-high has reached -4.47%.

Looking at its return of investments, which is 22.10%, and its return on assets is 13.60%. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has an operating margin of 18.70%. With a sales growth of 12.90% quarter over quarter. Bearing in mind that IDEXX Laboratories, Inc., IDXX is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of 1 and 0.8 for quick ratio.

So what is the value of IDEXX Laboratories, Inc.? Well its PEG is 3.55, and the P/S is 5.94, along with a P/B of *TBA. Meanwhile it has a p/cash of 27.14.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment